This suggests that KRT17TB can inhibit tumor budding to a certain extent.[33] Ugur has developed a method to predict colorectal cancer tumor budding based on preoperative hemoglobin, albumin, lymphocytes and platelets. This evidence concerns the gene ALB and neoplasm.